Congo vs Pakistan: Access to anti-retroviral drugs, female
Congo
33.0%
in 2024
Pakistan
24.0%
in 2024
Congo rank
133rd
Pakistan rank
136th
Access to anti-retroviral drugs, female over time
- Congo
- Pakistan
How they compare
Congo currently reports 33.0% against 24.0% in Pakistan, a difference of 9.0%.
That makes Congo's figure about 1.4 times Pakistan's.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Pakistan ahead.
Congo ranks 133rd and Pakistan ranks 136th of 141 countries.
Congo has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Congo | Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.1% | 2.4% | 0.7% | Congo |
| 2010s | 21.0% | 6.9% | 14.1% | Congo |
| 2020s | 28.2% | 17.8% | 10.4% | Congo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Congo or Pakistan?
- Congo, at 33.0% against 24.0% in Pakistan as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Congo and Pakistan?
- 9.0%, with Congo ahead.
- How many years of comparable data are there for Congo and Pakistan?
- 25 years are reported by both, from 2000 to 2024.
- How do Congo and Pakistan rank globally for access to anti-retroviral drugs, female?
- Congo ranks 133rd and Pakistan ranks 136th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.